Credit Suisse’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $9.19M | Sell |
171,314
-2,677
| -2% | -$144K | 0.01% | 951 |
|
|
2023
Q4 | $9.27M | Sell |
173,991
-9,586
| -5% | -$467K | 0.01% | 958 |
|
|
2023
Q3 | $9.11M | Buy |
183,577
+74,411
| +68% | +$4.16M | 0.01% | 941 |
|
|
2023
Q2 | $6.5M | Buy |
109,166
+6,585
| +6% | +$375K | 0.01% | 1164 |
|
|
2023
Q1 | $5.81M | Buy |
102,581
+2,030
| +2% | +$130K | 0.01% | 1208 |
|
|
2022
Q4 | $7.47M | Sell |
100,551
-19,738
| -16% | -$1.34M | 0.01% | 1069 |
|
|
2022
Q3 | $7.17M | Sell |
120,289
-9,414
| -7% | -$567K | 0.01% | 1065 |
|
|
2022
Q2 | $7.28M | Buy |
129,703
+11,988
| +10% | +$788K | 0.01% | 1083 |
|
|
2022
Q1 | $8.69M | Sell |
117,715
-1,345
| -1% | -$93.5K | 0.01% | 1109 |
|
|
2021
Q4 | $8.6M | Sell |
119,060
-21,358
| -15% | -$1.55M | ﹤0.01% | 1620 |
|
|
2021
Q3 | $10.8M | Sell |
140,418
-38,879
| -22% | -$3.12M | 0.01% | 1489 |
|
|
2021
Q2 | $13.7M | Buy |
179,297
+11,927
| +7% | +$848K | 0.01% | 1367 |
|
|
2021
Q1 | $10.3M | Sell |
167,370
-1,967
| -1% | -$125K | 0.01% | 1572 |
|
|
2020
Q4 | $11M | Sell |
169,337
-19,454
| -10% | -$1.12M | 0.01% | 1515 |
|
|
2020
Q3 | $9.35M | Buy |
188,791
+43,650
| +30% | +$2.25M | 0.01% | 1409 |
|
|
2020
Q2 | $6.92M | Buy |
145,141
+31,501
| +28% | +$1.52M | 0.01% | 1506 |
|
|
2020
Q1 | $4.83M | Sell |
113,640
-32,078
| -22% | -$1.58M | ﹤0.01% | 1568 |
|
|
2019
Q4 | $8.58M | Buy |
145,718
+35,687
| +32% | +$1.94M | 0.01% | 1504 |
|
|
2019
Q3 | $5.63M | Sell |
110,031
-6,638
| -6% | -$316K | ﹤0.01% | 1665 |
|
|
2019
Q2 | $4.93M | Sell |
116,669
-12,415
| -10% | -$539K | ﹤0.01% | 1769 |
|
|
2019
Q1 | $6.38M | Sell |
129,084
-35,110
| -21% | -$1.59M | 0.01% | 1531 |
|
|
2018
Q4 | $7.11M | Buy |
164,194
+36,835
| +29% | +$1.84M | 0.01% | 1370 |
|
|
2018
Q3 | $7.23M | Sell |
127,359
-17,223
| -12% | -$906K | 0.01% | 1459 |
|
|
2018
Q2 | $7.3M | Sell |
144,582
-4,765
| -3% | -$248K | 0.01% | 1460 |
|
|
2018
Q1 | $7.44M | Buy |
149,347
+10,757
| +8% | +$506K | 0.01% | 1435 |
|
|
2017
Q4 | $5.7M | Sell |
138,590
-44,075
| -24% | -$1.54M | 0.01% | 1692 |
|
|
2017
Q3 | $5.43M | Buy |
182,665
+55,034
| +43% | +$1.68M | 0.01% | 1704 |
|
|
2017
Q2 | $4.23M | Buy |
127,631
+59
| +0% | +$1.85K | ﹤0.01% | 1744 |
|
|
2017
Q1 | $3.78M | Sell |
127,572
-21,306
| -14% | -$581K | ﹤0.01% | 1860 |
|
|
2016
Q4 | $3.69M | Sell |
148,878
-28,039
| -16% | -$637K | ﹤0.01% | 1891 |
|
|
2016
Q3 | $3.99M | Buy |
176,917
+1,436
| +0.8% | +$33.8K | ﹤0.01% | 1831 |
|
|
2016
Q2 | $4.18M | Sell |
175,481
-48,230
| -22% | -$1.16M | ﹤0.01% | 1764 |
|
|
2016
Q1 | $5.31M | Buy |
223,711
+121,358
| +119% | +$2.97M | 0.01% | 1487 |
|
|
2015
Q4 | $2.85M | Sell |
102,353
-94,565
| -48% | -$2.37M | ﹤0.01% | 2032 |
|
|
2015
Q3 | $4.07M | Buy |
196,918
+53,244
| +37% | +$1.35M | ﹤0.01% | 1706 |
|
|
2015
Q2 | $3.69M | Buy |
143,674
+81,302
| +130% | +$2.06M | ﹤0.01% | 2009 |
|
|
2015
Q1 | $1.57M | Sell |
62,372
-38,673
| -38% | -$942K | ﹤0.01% | 2595 |
|
|
2014
Q4 | $2.4M | Sell |
101,045
-970
| -1% | -$21.5K | ﹤0.01% | 2394 |
|
|
2014
Q3 | $2.01M | Sell |
102,015
-44,138
| -30% | -$908K | ﹤0.01% | 2486 |
|
|
2014
Q2 | $3.5M | Buy |
146,153
+100,212
| +218% | +$2.42M | ﹤0.01% | 2262 |
|
|
2014
Q1 | $1.22M | Sell |
45,941
-24,601
| -35% | -$585K | ﹤0.01% | 2951 |
|
|
2013
Q4 | $1.42M | Buy |
70,542
+31,372
| +80% | +$582K | ﹤0.01% | 2979 |
|
|
2013
Q3 | $684K | Sell |
39,170
-48,427
| -55% | -$838K | ﹤0.01% | 3272 |
|
|
2013
Q2 | $1.48M | Buy |
+87,597
| New | +$1.35M | ﹤0.01% | 2491 |
|
Other funds holding GMED
CIP
CCM
BAM
HRCM
Credit Suisse's GMED Position: Q1 2024 in Review
Credit Suisse reduced its Globus Medical (GMED) stake by 1.5% in Q1 2024, selling an estimated $144K and leaving 171,314 shares worth $9.19M. The position accounts for 0.01% of the portfolio, ranked #951.
Credit Suisse first reported a position in GMED in Q2 2013 and has held it in 44 quarters since. The position peaked at $13.7M in Q2 2021. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.
- Credit Suisse held 171,314 shares of Globus Medical worth $9.19M as of Q1 2024.
- Credit Suisse sold 2,677 Globus Medical shares in Q1 2024, an estimated $144K.
- Globus Medical made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #951 holding.
- Credit Suisse first reported a position in Globus Medical in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Globus Medical position peaked at $13.7M in Q2 2021.
- 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.